Advances in Diagnosis and Therapeutic Guidance for Acute Coronary Syndrome: A Narrative of A Precision Medicine Approach
inhibitor monotherapy. Secondary prevention extends beyond lipid-lowering therapies and includes metabolic and anti-inflammatory interventions. Collectively, these advancements indicate a shift toward truly personalized care for ACS, aiming to improve outcomes by transitioning away from a one-size-fits-all approach.
Authors
- Kenji Yaginuma (ORCID: https://orcid.org/0009-0000-0694-3518)
- Kikuo Isoda
- Tomiharu Niida (ORCID: https://orcid.org/0000-0001-9665-4102)
- Takuma Koike (ORCID: https://orcid.org/0000-0001-6360-3181)
- Seiji Koga
- Kenji Inoue
Institutions
- Heart Rhythm Society (US)
- Juntendo University (JP)
- Juntendo University Nerima Hospital (JP)
Publication Details
- Journal
- Reviews in Cardiovascular Medicine
- Published
- 2026-04-14
- DOI
- https://doi.org/10.31083/rcm39947
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sysmex Corporation
- Roche Diagnostics